Skip to content
State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF technical analysis

XBIHealth Updated daily

Technical analysis of State Street SPDR S&P Biotech ETF (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is State Street SPDR S&P Biotech ETF

The State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the performance of the S&P Biotechnology Select Industry Index through a sampling strategy. The fund invests at least 80% of its assets in the securities comprising the index, which represents the biotechnology segment of the S&P Total Market Index.

Description generated automatically from public sources; it may be inaccurate or out of date.

State Street SPDR S&P Biotech ETF: latest session data

Closing values for September 4, 2026, computed on the last 12 months of prices.

Close163.81 $
Change−0.35%
RSI (14)55.2
MACD2.674
ADX21.4
Volatility (ATR)2.48%
Volume vs 20-avg47%
12-month high169.89 $
12-month low118.07 $

Moving averages

21 sessions

162.72 $

+0.67%

50 sessions

158.08 $

+3.62%

200 sessions

135.23 $

+21.14%

Session levels

s2

161.29

Support

s1

162.83

Support

pivot

164.40

Pivot

r1

165.94

Resistance

r2

167.51

Resistance

How to read it

In the September 4, 2026 session State Street SPDR S&P Biotech ETF closed lower at 163.81 $, −0.35% versus the previous session.

The price sits above every moving average observed: +0.67% against the 21-session average, +3.62% against the 50 and +21.14% against the 200.

The 14-period RSI reads 55.2, in neutral territory.

MACD stands at 2.674 against a signal line at 3.140: the histogram is negative (−0.467).

ADX reads 21.4, indicating weak directionality.

Levels computed on the latest session place supports at 162.83 and 161.29 $ and resistances at 165.94 and 167.51 $, around a pivot of 164.40.

The average daily range (ATR) is 4.058 $, or 2.48% of price.

Turnover was 3.8M shares, 47% of the 20-session average.

Over the last twelve months the price ranged between 118.07 and 169.89 $, and today stands −3.58% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of State Street SPDR S&P Biotech ETF

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the XBI analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about State Street SPDR S&P Biotech ETF

How is State Street SPDR S&P Biotech ETF analysed technically?

Technical analysis of State Street SPDR S&P Biotech ETF is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for State Street SPDR S&P Biotech ETF?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to State Street SPDR S&P Biotech ETF?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to State Street SPDR S&P Biotech ETF it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.